Psychiatry

Sort by Default

Display 15 Products per page

Extremity Replacement Implants

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for extremities replacement implants. Market forecasts and competitive analyses are provided for the shoulder, elbow, ankle, and small joint arthroplasty devices markets. Geographic segments covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.
December 8, 2022
Find out more
Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices

$4,750.00

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for PVD therapeutic devices; these include percutaneous transluminal angioplasty devices, vascular stents, atherectomy devices, thrombectomy devices, and chronic total occlusion crossing devices.
September 22, 2022
Find out more
Interventional Neurology: Mechanical Thrombectomy Devices

$4,750.00

Mechanical thrombectomy (MT) is an emergency surgical technique used in eligible patients experiencing acute ischemic stroke (AIS) to remove a blood clot in the brain. In 2021, the combined global market for neuroendovascular MT devices was estimated at approximately $706m.
June 14, 2022
Find out more
Drug Delivery: Transdermal Devices

$4,750.00

This chapter provides a discussion of the sales, competitors, drivers, and limiters of the transdermal drug delivery devices market in the areas of cardiovascular disease (CVD; eg angina pectoris and hypertension), neurological disorders (eg attention deficit hyperactivity disorder [ADHD], major depressive disorder [MDD], Alzheimer’s disease, and Parkinson’s disease), hormone replacement therapy (HRT; eg menopause and osteoporosis treatment), and pain management (eg fentanyl- and lidocaine-based chronic pain treatment). Markets covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets.
May 26, 2022
Find out more
Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

$4,750.00

This report provides an overview of primary neurological diseases/disorders treated with deep brain stimulation (DBS) and vagus nerve stimulation (VNS), as well as overviews of DBS and VNS neuromodulation technologies, competitors, sales, forecasts, and competitive and market analysis. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.
May 26, 2022
Find out more
Neuromodulation: Spinal Cord Stimulation Devices Market

$4,750.00

According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.
February 22, 2022
Find out more
Interventional Cardiology: Carotid Artery Stents and Embolic Protection Systems

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for carotid artery stents and embolic protection systems. Geographically
September 9, 2021
Find out more
Respiratory Care: Noninvasive Ventilation and Airway Management Products

$4,750.00

Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).

December 17, 2020
Find out more
United Kingdom, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union member state of the U.K.
September 22, 2016
Find out more
France, Disease Incidence and Prevalence

$4,850.00

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry.

September 22, 2016
Find out more
U.S. Markets for Heart Valve Disorder Management Products

$4,750.00

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.
September 22, 2016
Find out more
U.S. Neurostimulation Devices Market, June 2015

$5,250.00

An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime.
September 22, 2016
Find out more
Global Neurostimulation Devices Market, June 2016

$4,750.00

The large and burgeoning global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide. Despite lingering economic uncertainty and financial constraints that have affected many other medical device markets, this market is undergoing significant technological advancement due to heavy R&D and investment efforts by dozens of innovative startups and leading medical device companies.
June 1, 2016
Find out more
Asia-Pacific Disease Incidence and Prevalence

$5,250.00

The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.
January 1, 2016
Find out more
U.S. Surgical Procedure Volumes

$4,750.00

This report presents the most common surgical procedures performed in the United States (U.S.) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.
November 1, 2015
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 - 12 St. James's Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Call Back

Name

Email *

Company name *

Phone number *